| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |